screen
children
sever
respiratori
syncyti
viru
rsv
diseas
children
mild
rsv
diseas
human
metapneumoviru
hmpv
although
hmpv
circul
connecticut
none
rsvinfect
patient
test
posit
hmpv
studi
popul
hmpv
contribut
sever
rsv
diseas
n
unit
state
infant
young
children
hospit
year
respiratori
syncyti
viru
rsv
bronchiol
although
risk
factor
sever
rsv
diseas
prematur
bronchopulmonari
dysplasia
well
defin
sever
rsv
diseas
may
develop
otherwis
healthi
children
pathogenesi
sever
rsv
diseas
poorli
defin
van
den
hoogen
et
al
report
isol
novel
paramyxoviru
human
metapneumoviru
hmpv
children
respiratori
tract
diseas
hmpv
identifi
worldwid
appear
season
distribut
winter
spring
sinc
circul
hmpv
may
overlap
rsv
simultan
infect
rsv
hmpv
may
contribut
sever
diseas
greensil
et
al
report
rsvinfect
children
requir
admiss
pediatr
intens
care
unit
picu
liverpool
uk
coinfect
hmpv
sought
determin
whether
infect
hmpv
associ
sever
rsv
diseas
determin
frequenc
hmpv
infect
children
either
mild
sever
rsv
diseas
diseas
sever
assess
disposit
picu
vs
nonpicu
clinic
sever
score
part
ongo
epidemiolog
studi
viral
respiratori
infect
children
collect
rsv
direct
fluoresc
antibodi
dfa
posit
respiratori
specimen
clinic
virolog
laboratori
yalenew
hospit
novemb
octob
respiratori
specimen
also
screen
dfa
parainfluenza
virus
influenza
b
virus
adenovirus
rsvposit
patient
also
test
posit
one
virus
list
exclud
studi
rsvposit
children
admit
picu
yearlong
period
identifi
peak
time
infect
rsv
hmpv
may
differ
rsvposit
child
picu
match
date
diagnosi
child
mild
rsv
diseas
rsvposit
children
admit
picu
diagnos
within
day
diagnosi
picuadmit
child
identifi
child
whose
age
close
match
age
picuadmit
child
select
child
diagnos
rsv
identifi
within
day
picuadmit
child
child
closest
date
diagnosi
identifi
match
picuadmit
patient
rna
extract
revers
transcriptionpolymeras
chain
reaction
rtpcr
perform
previous
describ
primer
use
amplif
rsv
l
gene
follow
forward
primer
genom
locat
refer
strain
rsv
melbourn
genbank
access
revers
primer
genom
locat
genbank
access
hmpv
forward
primer
hmpv
genom
locat
genbank
access
gc
clamp
underlin
revers
primer
genbank
access
gc
clamp
underlin
use
amplif
hmpv
f
gene
base
region
f
gene
conserv
new
netherland
australian
strain
pcr
reaction
perform
use
hotstar
qiagen
inc
valencia
ca
amplif
cycl
follow
min
follow
cycl
min
min
min
final
cycl
set
reaction
contain
appropri
neg
water
posit
control
sampl
rt
hmpvposit
nasal
wash
pcr
hmpv
cdna
step
clinic
sever
score
css
adapt
sever
score
describ
martinello
et
al
two
point
assign
patient
requir
positivepressur
ventilatori
support
ill
one
point
assign
follow
hospit
admiss
hospit
day
oxygen
satur
least
one
measur
use
supplement
oxygen
therefor
css
rang
medic
record
patient
abstract
score
review
know
patient
hmpv
statu
basi
publish
literatur
expect
frequenc
rsvhmpv
coinfect
picu
patient
approxim
nonpicu
patient
closer
dfanegativehmpvposit
infect
rate
found
popul
dfaneg
refer
sampl
test
neg
rsv
parainfluenza
virus
influenza
virus
adenoviru
power
calcul
perform
use
pass
j
hintz
ncss
pass
number
cruncher
statist
system
kaysvil
utah
use
power
sampl
patient
group
would
suffici
support
find
vs
use
power
calcul
patient
group
would
provid
adequ
power
show
littl
differ
proport
coinfect
two
group
comparison
made
use
chisquar
test
wilcoxon
rank
sum
test
appropri
tabl
exact
confid
interv
calcul
sa
sa
institut
cari
nc
twentythre
rsv
dfaposit
patient
admit
picu
studi
period
match
patient
identifi
demograph
clinic
inform
obtain
patient
medic
record
children
admit
picu
known
predispos
risk
factor
sever
rsv
diseas
picuadmit
children
css
css
eighteen
picu
patient
hospit
day
none
rsvposit
patient
admit
picu
test
posit
hmpv
rtpcr
children
mild
rsv
diseas
initi
seen
emerg
depart
accord
sever
ill
either
discharg
admit
pediatr
ward
eight
patient
mild
rsv
diseas
group
admit
hospit
although
children
hospit
day
css
rang
group
patient
css
none
patient
posit
hmpv
rtpcr
statist
signific
differ
picu
group
mild
diseas
group
observ
admiss
age
median
age
week
vs
week
p
hospit
admiss
rate
vs
p
css
median
css
vs
p
x
tabl
posit
pressur
ventil
requir
picu
patient
patient
need
day
none
patient
screen
either
group
rsvdfa
posit
patient
evid
hmpv
infect
p
ensur
method
rtpcr
adequ
perform
rtpcr
rsv
patient
respiratori
specimen
overal
children
posit
rtpcr
test
rsv
possibl
hmpv
play
role
pathogenesi
infect
respiratori
virus
known
import
identifi
hmpv
person
sar
remain
explain
greensil
et
al
observ
coinfect
rate
hmpv
rsv
coinfect
rate
among
intub
infant
hmpv
rsv
admit
picu
although
greensil
et
al
includ
appropri
control
group
studi
find
suggest
coinfect
hmpv
rsv
common
togeth
two
virus
may
contribut
increas
sever
diseas
observ
hmpv
infect
children
either
mild
sever
rsv
diseas
find
explain
absenc
hmpv
connecticut
furthermor
match
children
mild
rsv
diseas
children
sever
rsv
diseas
date
diagnosi
elimin
possibl
tempor
distribut
virus
might
influenc
result
potenti
differ
sensit
screen
test
use
greensil
et
al
group
like
account
differ
observ
rate
coinfect
use
similar
rtpcrbase
approach
confid
method
detect
hmpv
sensit
specif
observ
rate
hmpv
respiratori
specimen
previou
studi
compar
rate
observ
elsewher
furthermor
previou
studi
use
sequenc
analysi
rtpcr
amplicon
confirm
identif
hmpv
increas
preval
hmpv
liverpool
uk
may
account
high
rate
rsvhmpv
coinfect
observ
greensil
et
al
although
data
point
support
hypothesi
rel
small
sampl
size
limit
power
analysi
howev
basi
sampl
size
calcul
power
patient
number
suffici
detect
differ
rate
hmpv
infect
nonpicu
group
nonetheless
result
demonstr
rate
coinfect
low
patient
confid
interv
studi
also
support
find
frequenc
coinfect
hmpv
rsv
rare
basi
pathogenesi
sever
rsv
diseas
multifactori
sinc
sever
rsv
diseas
may
develop
appar
healthi
children
known
host
risk
factor
complet
account
instanc
sever
ill
preexist
matern
acquir
immun
innat
immun
viral
factor
genotyp
environ
like
contribut
diseas
pathogenesi
although
detect
coinfect
hmpv
may
worsen
rsv
diseas
small
percentag
infant
nonetheless
hmpv
like
play
import
role
sever
rsv
diseas
popul
